CTSO News and Press, CytoSorbents Corporation From 08/08/25

2025-08-08 13:23:38 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call Transcript Cytosorbents outlines plans for DrugSorb-ATR appeal and targets breakeven core business by se...

2025-08-07 16:26:03 ET More on Cytosorbents Cytosorbents outlines plans for DrugSorb-ATR appeal and targets breakeven core business by second half 2025 Cytosorbents Non-GAAP EPS of -$0.06, revenue of $8.73M misses by $0.28M Seeking Alpha’s Quant Rating on Cyto...

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON, N.J. , Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the in...

Leatt Corp (LEAT) is expected to report for Q2 2025 MDU Resources Group Inc. (Holding Company) (MDU) is expected to report $0.13 for Q2 2025 Video Display Corp. (VIDE) is expected to report for quarter end 2025-05-31 Alarm.com Holdings Inc. (ALRM) is expected to report $0.38 for Q2 20...

CytoSorbents Corporation (CTSO) is expected to report $-0.06 for Q2 2025

CytoSorbents Leads a New Era in Sepsis Treatment PR Newswire CytoSorbents highlights the vital and evolving role of CytoSorb® in the treatment of sepsis and septic shock ahead of its World Sepsis Day Global Webinar on September 10 th PRINCETON, N.J. ...

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J. , July 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in th...

2025-07-02 14:30:43 ET Inspira Technologies Rallies 25% on $22.5M Order for FDA-Cleared Respiratory System Inspira Technologies OXY B.H.N. Ltd. ( $ IINN ) surged 25.34% to lead the PRISM Emerging MedDevices Index after securing a binding $22.5 million purchase order for ...

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR PR Newswire PRINCETON, N.J. , July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in...

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR PR Newswire PRINCETON, N.J. , June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening c...